Search Result
Results for "
DMG
" in MedChemExpress (MCE) Product Catalog:
81
Biochemical Assay Reagents
2
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-112764
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
-
- HY-Y0511
-
|
Dimethylglycine; DMG; N-Methylsarcosine
|
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine (Dimethylglycine), a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine has antidepressant-like and surfactant effects .
|
-
-
- HY-167036
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Mal is a pegylated lipid with a molecular weight of 2000. DMG-PEG-Mal serves as a component of lipid nanoparticles for mRNA delivery .
|
-
-
- HY-145411
-
|
|
Liposome
|
Endocrinology
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
-
- HY-W001158S
-
|
Dimethylglycine-d6 hydrochloride; DMG-d6 hydrochloride; N-Methylsarcosine-d6 hydrochloride
|
Isotope-Labeled Compounds
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine-d6 (Dimethylglycine-d6) hydrochloride is the deuterium labeled N,N-Dimethylglycine hydrochloride (HY-W001158). N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
-
-
- HY-147332
-
|
|
Liposome
|
Neurological Disease
|
|
TCL053 is an ionizable lipid carrier and used to introduce active components, in particular nucleic acids, into cells with excellent efriciency. TCL053, together with DPPC (Dipalmitoylphosphatidylcholine), PEG-DMG (Polyethylene glycoldimyristoyl glycerol), and cholesterol, forms lipid nanoparticle (LNP) which is able to deliver Cas9 mRNA and sgRNA into skeletal muscle .
|
-
-
- HY-N16040
-
|
|
Liposome
|
Others
|
|
DMG-pSar25 is a double lipid-tailed polysarcosine lipid with 25 sarcosine moieties, serving as a PEG lipid substitute in lipid nanoparticle formulations for mRNA delivery. DMG-pSar25 supports mRNA delivery in lipid nanoparticle formulations .
|
-
-
- HY-168399
-
|
|
Liposome
|
Cancer
|
|
PEG(2000)-C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol (HY-128468). PEG(2000)-C-DMG can be used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of siRNA .
|
-
-
- HY-174264
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-NHS is a polyethylene glycol lipid with a molecular weight of 2000, which can be used to construct novel drug delivery systems that confer mucoadhesive and cell-targeting capabilities to lipid nanoparticles .
|
-
-
- HY-148234
-
|
|
Anaplastic lymphoma kinase (ALK)
TGF-beta/Smad
|
Cancer
|
|
M4K2234, a chemical probe, is an orally active, highly selective inhibitor of ALK1 and ALK2 with IC50 values of 7 nM and 14 nM, respectively. M4K2234 specifically blocks BMP signaling by inhibiting the phosphorylation of SMAD1/5/8. M4K2234 inhibits BMP7-stimulated reporter gene activity (IC50 = 16 nM). M4K2234 can be used for the investigation of ALK1/2-mediated biological processes and related diseases such as diffuse midline glioma (DMG) and fibrodysplasia ossificans progressiva (FOP) .
|
-
-
- HY-N15956
-
|
|
Liposome
|
Others
|
|
DMG-PEG(2k)-DBCO is a Clickable PEG lipid containing a DBCO group. DSPE-PEG8-DBCO can be used to prepare lipid nanoparticles for drug delivery.
|
-
-
- HY-W001158
-
|
Dimethylglycine hydrochloride; DMG hydrochloride; N-Methylsarcosine hydrochloride
|
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
-
-
- HY-W440821
-
-
-
- HY-166983
-
|
|
Biochemical Assay Reagents
|
Others
|
|
m-PEG5000-DMG is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG5000-DMG can be used in drug delivery research .
|
-
-
- HY-Y0511R
-
|
Dimethylglycine (Standard); DMG (Standard); N-Methylsarcosine (Standard)
|
Reference Standards
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine (Dimethylglycine) (Standard) is the analytical standard of N,N-Dimethylglycine (HY-Y0511). This product is intended for research and analytical applications. N,N-Dimethylglycine (Dimethylglycine), a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine has antidepressant-like and surfactant effects.
|
-
-
- HY-112764GL
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
-
- HY-N15976
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-pSar25 Maleimide is a lipid conjugated to DMG, Maleimide and pSar25 polymer. DMG-pSar25 Maleimide can be used to prepare lipid nanoparticles for drug delivery.
|
-
-
- HY-W1049124A
-
|
|
Liposome
|
Cancer
|
|
PEG5000-C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol (HY-128468). PEG5000-C-DMG can be combined with other lipids to form lipid nanoparticles (LNPs) for the delivery of siRNA .
|
-
-
- HY-W1123934A
-
-
-
- HY-167036C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG5000-Mal can be used for drug delivery .
|
-
-
- HY-W1048669B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG10000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
-
- HY-W590555
-
|
|
Liposome
|
Cancer
|
|
Thiol-PEG2000-DMG is a phospholipid polyPEG which can be used to prepare liposomes or nanoparticles. The terminal thiol group reacts with maleimide, OPSS, vinylsulfone and transition metal surfaces including gold, silver, etc.
|
-
-
- HY-W1123940A
-
-
-
- HY-167036A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG1000-Mal can be used for drug delivery .
|
-
-
- HY-174264B
-
-
-
- HY-W1123940
-
-
-
- HY-174264C
-
-
-
- HY-W001158S1
-
|
Dimethylglycine-d3 hydrochloride; DMG-d3 hydrochloride; N-Methylsarcosine-d3 hydrochloride
|
Isotope-Labeled Compounds
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine-d3 (Dimethylglycine-d3) hydrochloride is the deuterium labeled N,N-Dimethylglycine hydrochloride (HY-W001158). N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
-
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
-
- HY-183127
-
|
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG1000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG1000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
-
- HY-183127D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG10000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG10000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
-
- HY-183127C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG5000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG5000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
-
- HY-183127B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG3400-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG3400-DMG can be used for research in biomaterial construction and drug delivery.
|
-
-
- HY-183127A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
BOC-NH-PEG2000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG2000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
-
- HY-W800830
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-Nitrophenyl Carbonate is a short reagent featuring a DMG lipid headgroup and a nitrophenyl carbonate, which is readily displaced by amine nucleophiles to form carbamate bonds under mild conditions.
|
-
-
- HY-182903D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG10000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-182903C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG5000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-182903A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG2000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-182903
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG1000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-182903B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG3400-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-183196
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG1000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-183196D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG10000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
-
- HY-183196C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG5000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183196A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG2000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG3400-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG10000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG5000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG2000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG1000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-200288B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183191
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG1000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG10000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG3400-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-167036D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG10000-Mal can be used for drug delivery .
|
-
- HY-167036B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG3400-Mal can be used for drug delivery .
|
-
- HY-183191C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG5000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG2000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG5000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183156D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG10000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG10000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183156B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG3400-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183156A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG2000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183156
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183156C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG5000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-W1048669A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG5000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669I
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG3400-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG2000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Biotin-PEG1000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-186175
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-Mal-Cys-penetratin is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal maleimide (Mal). DMG-PEG2000-Mal-Cys-penetratin combines the membrane compatibility of lipids, the specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers) by maleimide, and cell-penetrating peptides, making it suitable for research on biomaterial construction and drug delivery to cells.
|
-
- HY-W1123934D
-
-
- HY-W1123940C
-
-
- HY-W1123934C
-
-
- HY-W1123940D
-
-
- HY-W1123934
-
-
- HY-W1123934B
-
-
- HY-W1123940B
-
-
- HY-174264A
-
-
- HY-183132C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183132B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG3400-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183132D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG10000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183132A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG2000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183132
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG1000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-112764GL
-
|
|
Fluorescent Dyes
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
| Cat. No. |
Product Name |
Type |
-
- HY-112764
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-167036
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-Mal is a pegylated lipid with a molecular weight of 2000. DMG-PEG-Mal serves as a component of lipid nanoparticles for mRNA delivery .
|
-
- HY-145411
-
|
|
Biochemical Assay Reagents
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
- HY-147332
-
|
|
Biochemical Assay Reagents
|
|
TCL053 is an ionizable lipid carrier and used to introduce active components, in particular nucleic acids, into cells with excellent efriciency. TCL053, together with DPPC (Dipalmitoylphosphatidylcholine), PEG-DMG (Polyethylene glycoldimyristoyl glycerol), and cholesterol, forms lipid nanoparticle (LNP) which is able to deliver Cas9 mRNA and sgRNA into skeletal muscle .
|
-
- HY-174264
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-NHS is a polyethylene glycol lipid with a molecular weight of 2000, which can be used to construct novel drug delivery systems that confer mucoadhesive and cell-targeting capabilities to lipid nanoparticles .
|
-
- HY-W440821
-
|
|
Biochemical Assay Reagents
|
|
m-PEG-DMG (MW 2000) is a PEG lipid for the preparation of liposomes and can be used in drug delivery studies .
|
-
- HY-166983
-
|
|
Biochemical Assay Reagents
|
|
m-PEG5000-DMG is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG5000-DMG can be used in drug delivery research .
|
-
- HY-112764GL
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-W1123934A
-
-
- HY-167036C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG5000-Mal can be used for drug delivery .
|
-
- HY-W1048669B
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG10000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1123940A
-
-
- HY-167036A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG1000-Mal can be used for drug delivery .
|
-
- HY-174264B
-
-
- HY-W1123940
-
-
- HY-174264C
-
-
- HY-W1052148C
-
|
|
Biochemical Assay Reagents
|
|
mPEG550-DMG is a PEGylated phospholipid containing DMG. mPEG550-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764C
-
|
|
Biochemical Assay Reagents
|
|
mPEG500-DMG is a PEGylated phospholipid containing DMG. mPEG500-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764E
-
|
|
Biochemical Assay Reagents
|
|
mPEG30000-DMG is a PEGylated phospholipid containing DMG. mPEG30000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1049054C
-
|
|
Biochemical Assay Reagents
|
|
mPEG20000-DMG is a PEGylated phospholipid containing DMG. mPEG20000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764D
-
|
|
Biochemical Assay Reagents
|
|
mPEG750-DMG is a PEGylated phospholipid containing DMG. mPEG750-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148D
-
|
|
Biochemical Assay Reagents
|
|
mPEG1000-DMG is a PEGylated phospholipid containing DMG. mPEG1000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-W1052148B
-
|
|
Biochemical Assay Reagents
|
|
mPEG10000-DMG is a PEGylated phospholipid containing DMG. mPEG10000-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-112764B
-
|
|
Biochemical Assay Reagents
|
|
mPEG350-DMG is a PEGylated phospholipid containing DMG. mPEG350-DMG combines the membrane fusion capability of DMG with the stealth properties of PEG, and can be used for applications such as constructing targeted drug delivery systems and liposome preparation.
|
-
- HY-183127
-
|
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG1000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG1000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
- HY-183127D
-
|
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG10000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG10000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
- HY-183127C
-
|
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG5000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG5000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
- HY-183127B
-
|
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG3400-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG3400-DMG can be used for research in biomaterial construction and drug delivery.
|
-
- HY-183127A
-
|
|
Biochemical Assay Reagents
|
|
BOC-NH-PEG2000-DMG is a conjugate composed of a Boc-protected primary amine (-NH2), a PEG chain, and terminal dimyristoylglycerol (DMG). BOC-NH-PEG2000-DMG can be used for research in biomaterial construction and drug delivery.
|
-
- HY-182903D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG10000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-182903C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG5000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-182903A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG2000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-182903
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG1000-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-182903B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-Mannose is a conjugate composed of dimyristoylglycerol (DMG), a PEG chain, and terminal mannose. DMG-PEG3400-Mannose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of mannose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183196
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG1000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183196D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG10000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183196C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG5000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183196A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-Galactose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal galactose. DMG-PEG2000-Galactose combines the membrane compatibility of phospholipids with the targeted recognition capabilities of galactose, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG3400-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG10000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG5000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG2000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183398
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-CHO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal aldehyde group (-CHO). DMG-PEG1000-CHO combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-200288B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183191
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG1000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG10000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183191B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG3400-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-167036D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG10000-Mal can be used for drug delivery .
|
- HY-167036B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG3400-Mal can be used for drug delivery .
|
- HY-183191C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG5000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183191A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG2000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183195C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG5000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183195B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183156D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG10000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183195D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG10000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183156B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG3400-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183195A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183156A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG2000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183156
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183156C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG5000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-W1048669A
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG5000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
- HY-W1048669I
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG3400-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
- HY-W1048669H
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG2000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
- HY-W1048669E
-
|
|
Biochemical Assay Reagents
|
|
Biotin-PEG1000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
- HY-W1123934D
-
- HY-W1123940C
-
- HY-W1123934C
-
- HY-W1123940D
-
- HY-W1123934
-
- HY-W1123934B
-
- HY-W1123940B
-
- HY-174264A
-
- HY-183132C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183132B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG3400-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183132D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG10000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183132A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG2000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
- HY-183132
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG1000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
|
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-W001158
-
|
Dimethylglycine hydrochloride; DMG hydrochloride; N-Methylsarcosine hydrochloride
|
Endogenous Metabolite
iGluR
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
|
|
N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-W001158S
-
|
|
|
N,N-Dimethylglycine-d6 (Dimethylglycine-d6) hydrochloride is the deuterium labeled N,N-Dimethylglycine hydrochloride (HY-W001158). N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
-
-
- HY-W001158S1
-
|
|
|
N,N-Dimethylglycine-d3 (Dimethylglycine-d3) hydrochloride is the deuterium labeled N,N-Dimethylglycine hydrochloride (HY-W001158). N,N-Dimethylglycine (Dimethylglycine) hydrochloride, a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine hydrochloride is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine hydrochloride has antidepressant-like and surfactant effects .
|
-
| Cat. No. |
Product Name |
|
Classification |
-
- HY-183191
-
|
|
|
Alkynes
|
|
DMG-PEG1000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG1000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191D
-
|
|
|
Alkynes
|
|
DMG-PEG10000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG10000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191B
-
|
|
|
Alkynes
|
|
DMG-PEG3400-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG3400-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191C
-
|
|
|
Alkynes
|
|
DMG-PEG5000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG5000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183191A
-
|
|
|
Alkynes
|
|
DMG-PEG2000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG2000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195C
-
|
|
|
DBCO
|
|
DMG-PEG5000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG5000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195B
-
|
|
|
DBCO
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195D
-
|
|
|
DBCO
|
|
DMG-PEG10000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG10000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
-
- HY-183195A
-
|
|
|
DBCO
|
|
DMG-PEG2000-DBCO is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal dibenzocyclooctylene (DBCO). DMG-PEG2000-DBCO combines the membrane compatibility of phospholipids with the high reactivity of the DBCO group in copper-free click chemistry, making it suitable for research in biomaterial construction and drug delivery.
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-112764
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-167036
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG2000-Mal is a pegylated lipid with a molecular weight of 2000. DMG-PEG-Mal serves as a component of lipid nanoparticles for mRNA delivery .
|
-
- HY-145411
-
|
|
|
Pegylated Lipids
|
|
PEG2000-C-DMG, a pegylated lipid, can be used for the preparation of Onpattro. Onpattro, a hepatically directed investigational RNAi therapeutic agent, harnesses this process to reduce the production of mutant and wild-type transthyretin by targeting the 3′ untranslated region of transthyretin mRNA .
|
-
- HY-147332
-
|
|
|
Cationic Lipids
|
|
TCL053 is an ionizable lipid carrier and used to introduce active components, in particular nucleic acids, into cells with excellent efriciency. TCL053, together with DPPC (Dipalmitoylphosphatidylcholine), PEG-DMG (Polyethylene glycoldimyristoyl glycerol), and cholesterol, forms lipid nanoparticle (LNP) which is able to deliver Cas9 mRNA and sgRNA into skeletal muscle .
|
-
- HY-168399
-
|
|
|
Pegylated Lipids
Polymers
|
|
PEG(2000)-C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol (HY-128468). PEG(2000)-C-DMG can be used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of siRNA .
|
-
- HY-174264
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG2000-NHS is a polyethylene glycol lipid with a molecular weight of 2000, which can be used to construct novel drug delivery systems that confer mucoadhesive and cell-targeting capabilities to lipid nanoparticles .
|
-
- HY-N15956
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG(2k)-DBCO is a Clickable PEG lipid containing a DBCO group. DSPE-PEG8-DBCO can be used to prepare lipid nanoparticles for drug delivery.
|
-
- HY-166983
-
|
|
|
Pegylated Lipids
|
|
m-PEG5000-DMG is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. m-PEG5000-DMG can be used in drug delivery research .
|
-
- HY-N15976
-
|
|
|
Pegylated Lipids
|
|
DMG-pSar25 Maleimide is a lipid conjugated to DMG, Maleimide and pSar25 polymer. DMG-pSar25 Maleimide can be used to prepare lipid nanoparticles for drug delivery.
|
-
- HY-W1049124A
-
|
|
|
Pegylated Lipids
|
|
PEG5000-C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol (HY-128468). PEG5000-C-DMG can be combined with other lipids to form lipid nanoparticles (LNPs) for the delivery of siRNA .
|
-
- HY-W1123934A
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG2000-SH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-167036C
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG5000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG5000-Mal can be used for drug delivery .
|
-
- HY-W1048669B
-
|
|
|
Pegylated Lipids
|
|
Biotin-PEG10000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W590555
-
|
|
|
Pegylated Lipids
|
|
Thiol-PEG2000-DMG is a phospholipid polyPEG which can be used to prepare liposomes or nanoparticles. The terminal thiol group reacts with maleimide, OPSS, vinylsulfone and transition metal surfaces including gold, silver, etc.
|
-
- HY-W1123940A
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG2000-OH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-167036A
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG1000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG1000-Mal can be used for drug delivery .
|
-
- HY-174264B
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG3400-NHS is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123940
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG1000-OH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-174264C
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG5000-NHS is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-167036D
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG10000-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG10000-Mal can be used for drug delivery .
|
-
- HY-167036B
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG3400-Mal is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG units and Maleimide (HY-W007324). Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. DMG-PEG3400-Mal can be used for drug delivery .
|
-
- HY-W1048669A
-
|
|
|
Pegylated Lipids
|
|
Biotin-PEG5000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669I
-
|
|
|
Pegylated Lipids
|
|
Biotin-PEG3400-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669H
-
|
|
|
Pegylated Lipids
|
|
Biotin-PEG2000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1048669E
-
|
|
|
Pegylated Lipids
|
|
Biotin-PEG1000-DMG is a compound composed of biotin, PEG, and myristoyl-sn-glycerol, used for drug delivery. Biotin forms a stable non-covalent bond with streptavidin.
|
-
- HY-W1123934D
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG10000-SH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123940C
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG5000-OH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123934C
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG5000-SH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123940D
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG10000-OH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123934
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG1000-SH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123934B
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG3400-SH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-W1123940B
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG3400-OH is a PEG derivative that can be used to construct drug delivery vehicles.
|
-
- HY-174264A
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG1000-NHS is a PEG derivative that can be used to construct drug delivery vehicles.
|
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-112764GL
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent:
